Seller record · xcelpeptides.com
Xcel Peptides
1 of 8 criteria could be checked against Standard v1.1, and it passes. 7 are not verified and count neither way.
Research vendor. Passes 1 of 8 criteria. 7 not verified, counting neither way. Recorded against Standard v1.1.
A research peptide storefront whose whole catalog sits behind an account. Every page requested redirects to a sign-in telling the visitor that an account gives access to the research use only catalog, so its catalog is not visible without an account.
Dispositions
| Code | Criterion | Disposition | Where it was read |
|---|---|---|---|
| S1 | Prescriber requirement | NOT VERIFIED | xcelpeptides.com |
| S2 | Prescription gating | NOT VERIFIED | xcelpeptides.com |
| S3 | Pharmacy identification | NOT VERIFIED | xcelpeptides.com |
| S4 | Compounding disclosure | NOT VERIFIED | xcelpeptides.com |
| S5 | Analytical documentation | NOT VERIFIED | xcelpeptides.com |
| S6 | Business address | NOT VERIFIED | xcelpeptides.com |
| S7 | Price disclosure | NOT VERIFIED | xcelpeptides.com |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
What was read, where, and on what date, for each disposition in the table above.
Enforcement documents on file: 1 warning letter
FDA warning letter 694608, issued December 2024, to Xcel Research LLCThe peptide products offered from xcelpeptides.com are unapproved new drugs intended for human use, despite research-only labeling.
A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.